HIV and AIDS Articles on:
| |
FDA-approved
Treatments Experimental
Treatments
Top
New Articles |  |
Articles
on HIV and AIDS Guidelines
|
| |||
Protease
Inhibitors (PIs) Note: Most PIs are now used in combination with low-dose ritonavir (Norvir) | |||
 | Agenerase (amprenavir) | ||
 | Aptivus (tipranavir) | ||
 | Crixivan (indinavir) | ||
 | Invirase (saquinavir ) | ||
 | Kaletra (lopinavir/ritonavir) | ||
 | Lexiva (fosamprenavir) | ||
 | Norvir (ritonavir) | ||
 | Prezista (darunavir) | ||
 | Reyataz (atazanavir) | ||
 | Viracept (nelfinavir) | ||
Nucleoside
/ Nucleotide Reverse Transcriptase Inhibitors (NRTIs) | |||
 | Combivir (zidovudine + lamivudine) | ||
 | Epivir (lamivudine; 3TC) | ||
 | Emtriva (emtricitabine; FTC) | ||
 | Epzicom (abacavir + lamivudine) | ||
 | Retrovir (zidovudine; AZT) | ||
 | Trizivir (abacavir + zidovudine +lamivudine) | ||
 | Truvada (tenofovir + emtricitabine) | ||
 | Videx (didanosine; ddI) | ||
 | Viread (tenofovir) | ||
 | Zerit (stavudine; d4T) | ||
 | Ziagen (abacavir) | ||
non
Nucleoside Reverse Transcriptase Inhibitors (nNRTIs) | |||
 | Intelence (etravirine) | ||
 | Rescriptor (delavirdine) | ||
 | Sustiva (efavirenz) | ||
 | Viramune (nevirapine) | ||
Entry
/ Fusion Inhibitors | |||
 | Fuzeon (enfuvirtide) | ||
 | Selzentry/Celsentri ( maraviroc) | ||
Fixed-dose
Combinations | |||
 | Atripla (efavirenz + emtricitabine + tenofovir) | ||
| Combivir (zidovudine + lamivudine) | ||
| Trizivir (abacavir + zidovudine + lamivudine) | ||
| Truvada (tenofovir + emtricitabine) | ||
Integrase
Inhibitors | |||
 | Isentress (raltegravir) | ||
| |||
